Publication:
Narrowband UVB therapy in the treatment of lichen planus

dc.contributor.buuauthorSarıcaoğlu, Hayriye
dc.contributor.buuauthorKaradoǧan, Serap Köran
dc.contributor.buuauthorBaşkan, Emel Bülbül
dc.contributor.buuauthorTunali, Şükran
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentDeri ve Zührevi Hastalıklar Ana Bilim Dalı
dc.contributor.orcid0000-0002-0144-3263
dc.contributor.researcheridAAH-1388-2021
dc.contributor.scopusid6603722836
dc.contributor.scopusid9738885800
dc.contributor.scopusid6602518817
dc.contributor.scopusid7004191748
dc.date.accessioned2021-09-13T10:44:26Z
dc.date.available2021-09-13T10:44:26Z
dc.date.issued2003-10
dc.description.abstractBackground: Recently, UVB lamps with a peak emission around 311 nm have been used successfully for the treatment of many dermatologic diseases known to be treated with psoralen plus UVA ( PUVA). Narrowband UVB (NBUVB) radiation causes less erythema and carcinogenicity with lower cumulative doses than PUVA, while the treatment response remains high. Lichen planus ( LP) is a cell-mediated immune response of unknown origin. Methods: We present our results of NBUVB therapy administered to 10 LP patients. The sessions were administered three to four times weekly with an average cumulative dose of 17.7 +/- 1.6 J/cm(2). Results: Five patients responded completely, and four were partially responsive at the end of the 30th session. Three of the partially responsive cases responded completely at the 31st, 36th and 51st sessions, respectively. Conclusion: Clinical improvements observed in our study as well as the potential advantages of NBUVB imply that it is an inevitable treatment alternative for resistant cases of LP.
dc.identifier.citationSarıcaoğlu, H. vd. (2003). “Narrowband UVB therapy in the treatment of lichen planus”. Photodermatology Photoimmunology & Photomedicine , 19(5), 265-267.
dc.identifier.endpage267
dc.identifier.issn0905-4383
dc.identifier.issue5
dc.identifier.pubmed14535898
dc.identifier.scopus2-s2.0-0141635266
dc.identifier.startpage265
dc.identifier.urihttps://doi.org/10.1034/j.1600-0781.2003.00051.x
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/full/10.1034/j.1600-0781.2003.00051.x
dc.identifier.urihttp://hdl.handle.net/11452/21888
dc.identifier.volume19
dc.identifier.wos000185082500007
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherWiley
dc.relation.journalPhotodermatology Photoimmunology & Photomedicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDermatology
dc.subjectImmunologic disease
dc.subjectLichen planus
dc.subjectNarrowband UVB therapy
dc.subject.emtreeAntihistaminic agent
dc.subject.emtreeSteroid
dc.subject.emtreeAdolescent
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeCellular immunity
dc.subject.emtreeClinical article
dc.subject.emtreeClinical observation
dc.subject.emtreeControlled study
dc.subject.emtreeFemale
dc.subject.emtreeHistopathology
dc.subject.emtreeHuman
dc.subject.emtreeImmunopathology
dc.subject.emtreeLichen planus
dc.subject.emtreeMale
dc.subject.emtreePhototherapy
dc.subject.emtreePriority journal
dc.subject.emtreeRadiation dose
dc.subject.emtreeTreatment outcome
dc.subject.emtreeTreatment planning
dc.subject.emtreeUltraviolet B radiation
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLichen planus
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshPhotosensitizing agents
dc.subject.meshPUVA therapy
dc.subject.meshRadiotherapy dosage
dc.subject.meshTreatment outcome
dc.subject.scopusLichen Planus; Vincent Stomatitis; Pemphigus
dc.subject.wosDermatology
dc.titleNarrowband UVB therapy in the treatment of lichen planus
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Deri ve Zührevi Hastalıklar Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: